Autocrine Production of β-Chemokines Protects CMV-Specific CD4⁺ T Cells from HIV Infection

• Joseph P. Casazza ,

  * E-mail: jcasazza@mail.nih.gov

  Affiliation Immunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Jason M. Brenchley,

  Affiliation Immunopathogenesis Unit, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Brenna J. Hill,

  Affiliation Immunopathogenesis Unit, Lab of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Ribka Ayana,

  Affiliation Immunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• David Ambrozak,

  Affiliation Immunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Mario Roederer,

  Affiliation ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Daniel C. Douek,

  Affiliation Human Immunology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Michael R. Betts,

  Affiliation Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Richard A. Koup

  Affiliation Immunology Laboratory, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯